Increased indexes of thrombin activation in advanced stages of hypertension

Haemostasis

Volumn 31, Issue 1, 2001, Pages 49-54

  Trifiletti, Aldo ^a,b   Scamardi, Rina ^a   Pizzoleo, Maria Antonia ^a   Sottilotta, Gianluca ^a   Barbera, Natale ^a   Frisina, Nicola ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

Blood pressure; Coagulation; Hypertension

Indexed keywords

FIBRINOPEPTIDE A; PROTHROMBIN; THROMBIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; THROMBOSIS; VASCULAR DISEASE;

EID: 0034944807     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048044     Document Type: Article

References (33)

1. Factors controlling thrombus formation on arterial lesions
2. Thrombosis and the development of atherosclerosis: Rokitansky revisited
3. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death
4. Haemostatic variables in arterial hypertension
5. Coagulation and inhibitory and fibrinolysis proteins in essential hypertension
6. Plasma concentration of coagulation and fibrinolysis factors and platelet function in hypertension
7. Platelet activation and prostacyclin release in essential hypertension
8. Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator-inhibitor-1 level in plasma
9. Low order correlations of lipoprotein(a) with other blood lipids and with coagulation and fibrinolysis parameters in hypertensive and diabetic patients
10. Fibrinolysis factors and lipid composition of the blood in treated and untreated hypertensive patients
11. A rapid turbidimetric micromethod in the determination of haemostatic and fibrinolytic disorders in arterial hypertensive patients of different ages
12. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension
13. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension
14. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide
15. Radioimmunoassay of human fibrinopeptide A
16. Measurement of fibrinopeptide A in human blood
17. The generation of fibrinopeptide A in clinical blood samples: Evidence for thrombin activity
18. The pathophysiology of the prethrombotic state in humans: Insight gained from studies using markers of hemostatic system activation
19. Prothrombotic and fibrinolytic function of normal and perturbed endothelium
20. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction
21. Temporal relation between ischemic episodes and activation of the coagulation system in unstable angina
22. Thrombin activity and early outcome in unstable angina pectoris
23. Blood pressure, stroke and coronary heart disease. 1. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
24. Prothrombin activation fragment 1 + 2 and thrombin-anti-thrombin-III complexes in plasma of patients with essential hypertension
25. Memorandum from a World Health Organization/International Society of Hypertension meeting
26. Antihypertensive drug treatment and fibrinolytic function
27. Effect of medium-term antihypertensive therapy on haemostatic parameters in patients with essential hypertension
28. Effects of spirapril and hydrochlorothiazide on platelet function and euglobin clot lysis time in patients with mild hypertension
29. Calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease
30. Prothrombin fragment 1.2 in both treated and untreated hypertensive patients
31. Thrombin-catalyzed activation of single chain bovine factor V
32. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation
33. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma